Cargando…
Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer
Both aptamers and siRNA technologies have now reached maturity, and both have been validated with a product in the market. However, although pegaptanib reached the market some time ago, there has been a slow process for new aptamers to follow. Today, some 40 aptamers are in the market, but many in c...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956146/ https://www.ncbi.nlm.nih.gov/pubmed/31888119 http://dx.doi.org/10.3390/pharmaceutics11120684 |